Document is current
Any future updates will be listed below
-
Authors
Talishinsky, Aleksandr
Ajijola, Olujimi A.
Khalsa, Sahib S.
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH) National Heart, Lung and Blood Institute (P01HL164311)
National Institutes of Health (NIH) National Institute of Mental Health (R01MH127225)
United States - Israel Binational Science Foundation (BSF2023143)
- License Information
-
More Information
Article History
Received: 6 August 2025
Accepted: 21 August 2025
First Online: 21 October 2025
Declarations
:
: AT has no competing interests to disclose. SSK has performed scientific consulting for Jannsen Pharmaceuticals. OAA has received honoraria from J&J Medtech/Biosense Webster, Biotronik, Boston Scientific, Abbott, and Medtronic; holds stock in Anumana, NeuCures, and nference; and is a cofounder of Neufera. OAA also has a pending patent on Aorticorenal ganglion for neuromodulation.
: AT has no competing interests to disclose. SSK has performed scientific consulting for Jannsen Pharmaceuticals. OAA has received honoraria from J&J Medtech/Biosense Webster, Biotronik, Boston Scientific, Abbott, and Medtronic; holds stock in Anumana, NeuCures, and nference; and is a cofounder of Neufera. OAA also has a pending patent on Aorticorenal ganglion for neuromodulation.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
